Five Cell & Gene Companies to Know in Europe
The cell and gene therapy market was valued at USD 6 billion in 2017 and is projected to exceed USD 35 billion in value by 2026. Moreover, these…
Tagged with Cellectis
André Choulika – Chairman & CEO, Cellectis, France
André Choulika, Chairman and CEO of Cellectis, discusses how UCART will revolutionize cell therapy as a universal gene-edited solution as opposed to…
Interview: André Choulika – Chairman and CEO, Cellectis,…
André Choulika, founder & CEO of Cellectis, reveals why the 21st century will be the century of gene editing and Cellectis will be one of the…
